Selected Recent Cross-Border Transactions
in the demerger of Haleon from GSK and its subsequent listing on the London Stock Exchange
Jun 2022
in its acquisition of certain entities of
Apr 2022
€160 million
in its acquisition of
Apr 2022
in its acquisition by a consortium led by
Mar 2022
$16 billion
in its cash and share acquisition of
Feb 2022
£965 million
in its transfer of certain intellectual property rights to Mr. Cooper's cloud-based technology platform for mortgage servicing to Sagent M&C, in exchange for a minority stake in
Feb 2022
in its equity investment in
Jan 2022
$760 million
in its business combination with
Jan 2022
$2.64 billion
